Dr. Goldman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
VCU Department of Neurology
Richmond, VA 23298Phone+1 804-827-1504
Education & Training
Rush University Medical CenterInternship, Internal Medicine, 1999 - 2000
Rush Medical College of Rush University Medical CenterClass of 1999
Certifications & Licensure
VA State Medical License 2006 - 2026
OH State Medical License 2003 - 2007
IL State Medical License 1999 - 2000
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- CMS Meaningful Use Stage 1 Certification EpicCare Inpatient - Core EMR, Epic Systems Corporation, 2012
Clinical Trials
- Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple Sclerosis Start of enrollment: 2013 Nov 01
- Effect of MD1003 in Progressive Multiple Sclerosis (SPI2) Start of enrollment: 2016 Dec 01
- Clinical Importance of Glucose Regulation in Relapsing MS Start of enrollment: 2016 Oct 01
Publications & Presentations
PubMed
- "Will the Real Demyelinating Disorder Please Stand Up?": From the National Multiple Sclerosis Society Case Conference Proceedings.Aisha Elfasi, Myla D Goldman, Claire Riley, Scott S Zamvil, Scott Douglas Newsome
Neurology(R) Neuroimmunology & Neuroinflammation. 2025-05-01 - Mood Disorder and Multimorbidity Complicating a Multiple Sclerosis Diagnosis: From the National Multiple Sclerosis Society Case Conference Proceedings.Jonathan D Krett, Claire Riley, Scott S Zamvil, Myla D Goldman, Scott D Newsome
Neurology(R) Neuroimmunology & Neuroinflammation. 2025-03-01 - Progressive Myelitis in a 63-Year-Old Woman: A Case Report From the National Multiple Sclerosis Society Case Conference Proceedings.Kimberly A DiMauro, Morgan E Heber, Jonathan Lee, Jeffrey A Cohen, Eoin P Flanagan
Neurology(R) Neuroimmunology & Neuroinflammation. 2025-03-01
Journal Articles
- Efficacy and Safety of 2 Fingolimod Doses vs Glatiramer Acetate for the Treatment of Patients with Relapsing-Remitting Multiple SclerosisMyla D Goldman, Amit Bar-Or, JAMA Neurology
Authored Content
- Efficacy and Safety of 2 Fingolimod Doses vs Glatiramer Acetate for the Treatment of Patients with Relapsing-Remitting Multiple SclerosisAugust 2020
Press Mentions
The Multiple Sclerosis Clinic(s) and Research at UVAApril 4th, 2018
Multiple Sclerosis: Smoking After Diagnosis Linked to Disease ProgressionSeptember 9th, 2015
Quitting Smoking After MS Diagnosis May Delay Disease ProgressionSeptember 8th, 2015- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
